Biomarker research in Parkinson’s disease: objective measures needed for patient stratification in future cause-directed trials

Autosomal recessive mutations in the development of Parkinson’s disease

(2010) Grisel Lopez et al.   Biomarkers in Medicine

Biomarkers in Parkinson’s disease: a funder’s perspective

(2010) Mark Frasier et al.   Biomarkers in Medicine

Biomarkers in Parkinson’s disease: a venture capitalist’s perspective

(2010) Jens W Eckstein   Biomarkers in Medicine

Imaging dopamine transporters in Parkinson’s disease

(2010) David J Brooks   Biomarkers in Medicine

Problems associated with fluid biomarkers for Parkinson’s disease

(2010) Jakob Nyhlén et al.   Biomarkers in Medicine

Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosis

(2010) Sara Cipriani et al.   Biomarkers in Medicine

Olfaction as a biomarker in Parkinson’s disease

(2010) James F Morley et al.   Biomarkers in Medicine

Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies

(2010) Brit Mollenhauer et al.   Biomarkers in Medicine

Transcranial ultrasound as a risk marker for Parkinson's disease

(2010) Daniela Berg   MOVEMENT DISORDERS

RNA biomarkers of Parkinson’s disease: developing tools for novel therapies

(2008) Gerrit Hennecke et al.   Biomarkers in Medicine

Metabolomic profiling to develop blood biomarkers for Parkinson's disease

(2008) M. Bogdanov et al.   BRAIN